study ties hormone use to breast cancer

Hi. I calculated your risk of cancer recurrence in ten years using a software program called Adjuvant Online. I have factored in such data as your tumor size, grade, age, hormone receptor status and treatment history in the calculation. The figure I'm presenting to you is your overall 10 year recurrence risk. It does not specify whether the recurrence will come in the form of distant metastases or local recurrence (nobody can know that for certain).

Yes,,my own doctor showed me such a study ,,thats how he convinced me to use an estrogen hrt patch,,,I use Vivelle and am quite happy with it,,,My gyno claims the "old" studies where not a good scientific study,,,he says it was all post menopausal women and that made the study biased. A good study is double blind and a good cross section of women ,,some of differnent ages and ethnic backgrounds . I personally would advise anyone to do a lot of homework on this ...

At this time there appear to be few strong reasons to use post-menopausal hormone therapy (combined PHT or ERT), other than possibly for the short-term relief of menopausal symptoms. Along with the increased risk of breast cancer, combined PHT also appears to increase the risk of heart disease, blood clots, and strokes.

Lobular breast cancer accounts for about 10 percent of invasive breast cancer -- the kind that threatens to spread -- according to the American Cancer Society. It can be treated with hormone-based therapies such as tamoxifen, but the tumors are more difficult to detect by mammograms, meaning it is often diagnosed in more advanced stages.

The Women's Health Initiative showed that combined HRT as Prempro (conjugated estrogen plus progestin formulation medroxyprogesterone acetate) increased the risk of breast cancer. Estrogen taken without a progestin (Premarin) did not increase risk of breast cancer. But you are correct that a progestin or progesterone needs to be taken with estrogen to protect the uterine lining from proliferation and risk of hyperplasia or cancer.

Introduction Estrogen and progesterone are female hormones produced by ovaries. A breast cancer is said to be hormone receptor positive if shows evidence of estrogen or progesterone receptors (cell components that will bind to these female hormone molecules to bring about changes with in the cell). Laboratory tests are performed after surgery or biopsy to determine if the breast cancer cells are hormone receptor positive.

I thought the jury was out once again on whether Prempro (HRT) actually does increase the risk of breast cancer beause the study is believed by some to be flawed. The study was composed of mostly older women, who are at a higher risk. Also, I thought over the counter natural hormone remedies are not regulated by the FDA, thus they dont know if linked to breast cancer. This information might become outdated as I am writing this.

3% of women who never used MHT developed breast cancer, compared to 8.3% of women who used the combination drug continually for five years. That’s roughly one extra cancer diagnosis for every 50 users." I was really young when I took ERT, and the benefits outweighed the risks - heart disease, osteoporosis, etc. I was also slammed into menopause, and the symptoms were debilitating. If you have a family history of BC, than the risks may not be for you.

, locoregional or distant recurrence or contralateral breast cancer), postmenopausal women with hormone receptor–positive breast cancer should consider an AI, either as primary adjuvant therapy for 5 years or sequentially after 2 to 3 years of tamoxifen to yield a total of 5 years of adjuvant endocrine therapy. Women who discontinue initial AI therapy before 5 years should consider using tamoxifen to bring the total duration of adjuvant therapy to 5 years.

My sister noticed a difference in her breast tissue and the cancer was discovered through an ultrasound. Does this type of breast cancer usually run in families?

We provide support and general information about breast cancer issues, but it would not be appropriate to make specific treatment recommendations over the Internet, especially when you already have (or have had) a surgeon, oncologist, and radiologist. These are all questions that would best be addressed by your treatment team, who have all of the information about your breast cancer and your general health hx. Best wishes...

------------------------------------------ Researchers have confirmed earlier studies that women who use birth control pills have a higher risk of developing breast cancer. New study findings were reported in the journal Cancer Epidemiology, Biomarkers & Prevention (Vol.11: 1375-1381). Because the growth of breast tissue depends on a woman’s hormones, researchers have focused on hormone containing drugs as one risk factor for breast cancer.

The data is from the first large study to analyze early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller. All these women would benefit from adjuvant Trastuzumab, also known as Herceptin, (for one year, the standard in America) -- along with adjuvant chemotherapy. This represents a shift in the way women with early-stage HER2 positive breast cancer should be assessed for risk of recurrence and considered for treatment, according to the study's author.

A leading group of cancer experts has issued new guidelines on the best way to use two classes of hormone therapies for estrogen receptor-positive breast cancer, the most common form of breast tumor.

The Breast center my sister goes to had done a study on Carboplatin and Taxol but I was just hoping to hear of more studies. I so much appreciate your time and help.

The doctors raised my dosage of hormone, and told me that I would be on it for the rest of my life. So to know that it can increase the risk of breast cancer is totally new to me. Thanks again.

cancers of the mouth and pharynx, larynx, esophagus, liver, colon, rectum and female breast. To link the cancer to alcohol use, they relied on surveys of more than 220,000 adults, 2009 U.S. mortality data, and sales data on alcohol consumption. Breast cancer accounted for the most common alcohol-related cancer deaths among women, with alcohol contributing to 15 percent of all breast cancer deaths.

Recent research has found that women with localized breast cancer are less likely to develop invasive cancer if they receive radiation after surgery. The researchers also found that treatment with the drug tamoxifen greatly reduced the risk of the recurrence of localized cancer. The study included patients with ductal carcinoma in situ (DCIS), the most common type of noninvasive breast cancer, who were followed for a median of 12.7 years.

coronary heart disease, stroke, breast cancer, ovarian cancer, lung cancer, colorectal cancer, hip fracture, pulmonary embolus, and death due to all causes. A lot of additional data was collected in order to compare similar groups of women in terms of other factors. The women were similar in terms of baseline risk factors for cardiovascular disease and cancer, although the women who had their ovaries removed were slightly older and slightly more likely to be using or have used hormone therapy.

I have asked my oncologist these questions and he just says that taking the AI's is the best proven way to try to stop the recurrence of breast cancer. What I am finding is that the "older" doctors have been doing it this way for 20+ years and are not willing to change. When I asked him to check my hormone levels - he said that was "garbage in garbage out" since hormone levels vary there is no reason to check them.

My wife has breast cancer,her2 positive and is on hercepton every 3 weeks,shes also taking arimidex for hormone therapy. She wants to quit smoking,is it ok for her to use a patch ?

Study ties hormone use to breast cancer

Common Questions and Answers about Study ties hormone use to breast cancer

hormone